Chemical synthesis of tea polyphenols and related compounds

Current Pharmaceutical Design

Volumn 19, Issue 34, 2013, Pages 6207-6217

  Asakawa, Tomohiro ^a   Hamashima, Yoshitaka ^a   Kan, Toshiyuki ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Catechin; EGCg; Flavanol; Gallate; Tea polyphenol

Indexed keywords

CATECHIN; EPICATECHIN; EPIGALLOCATECHIN; GALLOCATECHIN;

BIOLOGICAL ACTIVITY; CHEMICAL BOND; CYCLIZATION; DESS MARTIN OXIDATION; DIHYDROXYLATION; DRUG HYDROLYSIS; DRUG STRUCTURE; DRUG SYNTHESIS; MITSUNOBU REACTION; PRIORITY JOURNAL; REVIEW; RING OPENING; SOLID PHASE SYNTHESIS;

ANIMALS; CAMELLIA SINENSIS; CATECHIN; CYCLIZATION; HUMANS; MOLECULAR STRUCTURE; POLYPHENOLS;

EID: 84887929100     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319340012     Document Type: Review

References (34)

1. Nagle DG, Ferreira D, Zhou YD. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives. Phytochemistry 2006; 67: 1849-55.
2. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003; 43: 89-143.
3. Zaveri NT. Green tea and its polyphenolic catechins: medicinal uses in cancer and noncancer applications. Life Sci 2006; 78: 2073-80.
4. Sutherland BA, Rahman RMA, Appleton I. Mechanisms of action of green tea catechins, with a focus on ischemia-induced neurodegeneration. J Nutr Biochem 2006; 17: 291-306.
5. Gramza A, Korczak J, Amarowicz R. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Pol J Food Nutr Sci 2005; 14: 219-35.
6. Singh BN, Shankar S, Srivastava RK. Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications. Biochem Pharmacol 2011; 82: 1807-21.
7. Chacko SM, Thambi PT, Kuttan R, Nishigaki I. Beneficial effects of green tea: A literature review. Chinese Medicine 2010, 5: 13-21.
8. Bieschke J, Russ J, Friedrich RP, et al. EGCG remodels mature β-synuclein and amyloid-α fibrils and reduces cellular toxicity. Proc Natl Acad Sci USA 2010; 107: 9033-38.
9. Zhao Y, Jiang F, Liu P, Chen W, Yi K. Catechins containing a galloyl moiety as potential anti-HIV-1 compounds. Drug Discovery Today. 2012; 17: 630-35.
10. Oyama K, Yoshida K, Kondo T. Recent progress in the synthesis of flavonoids: from monomers to supra-complex molecules. Curr Org Chem 2011; 15: 2567-607.
11. Zaveri NT. Synthesis of a 3, 4, 5-Trimethoxybenzoyl ester analogue of epigallocatechin-3-gallate (EGCG): A potential route to the natural product green tea catechin, EGCG. Org Lett 2001; 3: 843-46.
12. 13C-labelled (+)-catechin and (C)-epicatechin. Eur J Org Chem 2001, 2379-84.
13. Li L, Chan TH. Enantioselective synthesis of epigallocatechin-3-gallate (EGCG), the active polyphenol component from green tea. Org Lett 2001; 3: 739-41.
14. Anderson JC, Headley C, Stapleton PD, Taylor PW. Asymmetric total synthesis of B-ring modified (t)-epicatechin gallate analogues and their modulation of a-lactam resistance in Staphylococcus aureus. Tetrahedron 2005; 61: 7703-11.
15. Krohn K, Ahmed I, John M. Enantioselective synthesis of flavan-3-ols using a Mitsunobu cyclization. Synthesis 2009; 779-86.
16. Higuchi, T.; Ohmori, K.; Suzuki, K. General and convenient approach to flavan-3-ols: Stereoselective synthesis of (t)-gallocatechin. Chem. Lett. 2006, 35, 1006-07.
17. N1 problem. Chem Lett 2009; 38: 934-35.
18. Ohmori K, Yano T, Suzuki K. General synthesis of epi-series catechins and their 3-gallates: reverse polarity strategy. Org Biomol Chem 2010; 8: 2693-96.
19. Stadlbauer S, Ohmori K, Hattori F, Suzuki K. A new synthetic strategy for catechin-class polyphenols: concise synthesis of (s)-epicatechin and its 3-O-gallate. Chem Commun 2012; 48: 8425-27.
20. 3-catalyzed cycloalkylation of aryl epoxides. J Org Chem 2008; 73: 4625-29.
21. Tanaka H, Chino A, Takahashi T. Reagent-controlled stereoselective synthesis of (±)-gallo-and (±)-epigallo-catechin gallates. Tetrahedron Lett 2012; 53: 2493-95.
22. Kitade M, Ohno Y, Tanaka H, Takahashi T. An efficient synthesis of (o)-epigallocatechin gallate by reductive intramolecular etherification. Synlett 2006; 2827-29.
23. Tanaka H, Miyoshi H, Chuang YC, Ando Y, Takahashi T. Solidphase synthesis of epigallocatechin gallate derivatives. Angew Chem Int Ed 2007; 46: 5934-37.
24. Tanaka H, Yamanouchi M, Miyoshi H, Hirotsu K, Tachibana H, Takahashi T. Solid-phase synthesis of a combinatorial methylated ()-epigallocatechin gallate library and the growth-inhibitory effects of these compounds on melanoma B16 cells. Chem Asian J 2010; 5: 2231-48.
25. Furuta T, Hirooka Y, Abe A, et al. Concise synthesis of dideoxyepigallocatechin gallate (DO-EGCG) and evaluation of its antiinfluenza virus activity. Bioorg Med Chem Lett 2007; 17: 3095-98.
26. Hirooka Y, Nitta M, Furuta T, Kan T. Efficient synthesis of optically active gallocatechin-3-gallate derivatives via 6-endo cyclization. Synlett 2008; 3234-38.
27. Yoshida A, Hirooka Y, Sugata Y, et al. Concise synthesis of catechin probes enabling analysis and imaging of EGCg. Chem Commun 2011; 47: 1794-96.
28. Tanaka T, Kusano R, Kouno I. synthesis and antioxidant activity of novel amphipathic derivatives of tea polyphenol. Bioorg Med Chem Lett 1998; 8: 1801-6.
29. Wan SB, Dou QP, Chan TH. Regiospecific and enantioselective synthesis of methylated metabolites of tea catechins. Tetrahedron 2006; 62: 5897-904.
30. Huo C, Dou QP, Chan TH. Synthesis of phosphates and phosphates-acetates hybrids of green tea polyphenol (a)-epigallocatechine-3-gallate (EGCG) and its G ring deoxy analogs as potential anticancer prodrugs. Tetrahedron Lett 2011; 52: 5478-83.
31. Zhong Y, Chiou YS, Pan MH, Shahidi F. Anti-inflammatory activity of lipophilic epigallocatechin gallate (EGCG) derivatives in LPS-stimulated murine macrophages. Food Chemistry 2012; 134: 742-8.
32. Mori S, Miyake S, Kobe T, et al. Enhanced anti-influenza A virus activity of (a)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: Effect of alkyl chain length. Bioorg Med Chem Lett 2008; 18: 4249-52.
33. Matsumura K, Kaihatsu K, Mori S, Cho HH, Kato N, Hyon SH. Enhanced antitumor activities of (E)-epigallocatechin-3-O-gallate fatty acid monoester derivatives in vitro and in vivo. Biochem Biophysic Res Commun 2008; 377: 1118-22.
34. Aihara Y, Yoshida A, Furuta T, et al. Regioselective synthesis of methylated epigallocatechin gallate via nitrobenzene-sulfonyl (Ns) protecting group. Bioorg Med Chem Lett 2009; 19: 4171-4.